Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

highnihilism Sep. 16 at 4:46 PM

S&P 500 → $IDXX Idexx Laboratories $TKO Tko $CI Cigna $PNC PNC Financial $SO Southern

0 · Reply

highnihilism Sep. 16 at 3:43 PM

Nasdaq 100 → $KHC Kraft Heinz Company $IDXX Idexx Laboratories $TEAM Atlassian $BIIB Biogen $REGN Regeneron Pharmaceuticals

0 · Reply

SmartMoneyTradez Sep. 16 at 2:39 PM

$MDB $UTHR $IDXX 100 dollar gappers. Short candidates imo if the market unravels $SPY

0 · Reply

BillionerOfKing Sep. 16 at 2:10 PM

$IDXX Current Stock Price: $643.88 Contracts to trade: $640 IDXX Sep 19 2025 Call Entry: $5.30 Exit: $9.44 ROI: 78% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

MoneyGroupLLC Sep. 13 at 10:29 AM

Enter: $IDXX OCT 17 2025 $640 CALLS Buy in Price: $24.50 - $24.80 Take Profit: $27.28 Stop Bleeding: $21.82 ROI Potential: 10% Exit Within: 28 Minutes https://moneygroup.us/alerts

0 · Reply

ZacksResearch Sep. 12 at 2:16 PM

$IDXX surged 58.8% in a year — what's fueling this growth? 🚀 👉 Strong momentum in CAG Diagnostics, with 7.5% organic revenue growth in Q2 2025 👉 Cloud-based software solutions like Vello seeing double-digit user growth 👉 Strong new business gains driving 11% international revenue growth Discover the full growth story here 👉 https://www.zacks.com/stock/news/2750573/should-you-add-idexx-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2750573-body-12204&ADID=SYND_STOCKTWITS_TWEET_2_2750573_BODY_12204

0 · Reply

ZacksResearch Sep. 12 at 1:07 PM

$IDXX — Buy now or wait? 🐾 The question on the table: whether IDEXX stock deserves a spot in your portfolio right now. Full bull/bear case on IDXX 👉 https://www.zacks.com/stock/news/2750573/should-you-add-idexx-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2750573-teaser-12164&ADID=SYND_STOCKTWITS_TWEET_2_2750573_TEASER_12164

0 · Reply

NVDAMillionaire Sep. 9 at 11:06 AM

$IDXX Outstanding article that hits the mark on IDXX's current state. So if you want to refresh your IDXX insights or learn about IDXX from scratch, this is a must read. https://beyondspx.com/quote/IDXX/analysis/idexx-s-innovation-engine-powers-through-pet-healthcare-headwinds-idxx

0 · Reply

StockAutoPro Sep. 8 at 12:54 AM

$IDXX: Buy target $640.99 Sell target $675.14 Positive trends in pet healthcare could boost shares in this veterinary diagnostic products manufacturer.

0 · Reply

StockAutoPro Sep. 7 at 5:04 PM

$IDXX: Buy target $640.99 Sell target $675.14 Strong earnings growth and robust pet adoption trends signal potential upside for this veterinary diagnostics stock.

0 · Reply

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 1:00 PM EDT - 14 days ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 9:35 PM EDT - 5 weeks ago

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY INSM ISRG RDNT

Aug 4, 2025, 5:55 PM EDT - 6 weeks ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 2:37 PM EDT - 6 weeks ago

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:48 PM EDT - 6 weeks ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 6 weeks ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 10:45 AM EDT - 6 weeks ago

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Aug 4, 2025, 9:10 AM EDT - 6 weeks ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 7:57 AM EDT - 6 weeks ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 6 weeks ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 6 weeks ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 17, 2025, 7:06 AM EDT - 2 months ago

IDEXX Laboratories: A Business With Strong Fundamentals

Jul 10, 2025, 7:00 AM EDT - 2 months ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 3 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 3 months ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 14, 2025, 2:35 PM EDT - 4 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 13, 2025, 2:30 PM EDT - 4 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 10:35 AM EDT - 4 months ago

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

May 1, 2025, 8:21 AM EDT - 4 months ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

May 1, 2025, 6:30 AM EDT - 4 months ago

IDEXX Laboratories Announces First Quarter Results

Apr 3, 2025, 1:30 PM EDT - 5 months ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Mar 17, 2025, 5:40 AM EDT - 6 months ago

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'

Mar 12, 2025, 6:24 AM EDT - 6 months ago

IDEXX Laboratories: A Top Dog In The Pet Care Market

Feb 13, 2025, 2:00 PM EST - 7 months ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Feb 10, 2025, 11:27 AM EST - 7 months ago

IDEXX Laboratories And Its Real Value

Feb 6, 2025, 2:31 PM EST - 7 months ago

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future

Feb 3, 2025, 11:31 AM EST - 8 months ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

ABBV MOH

Feb 3, 2025, 11:26 AM EST - 8 months ago

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

Feb 3, 2025, 11:22 AM EST - 8 months ago

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Feb 3, 2025, 9:51 AM EST - 8 months ago

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

Feb 3, 2025, 7:57 AM EST - 8 months ago

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

Feb 3, 2025, 6:30 AM EST - 8 months ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

Jan 16, 2025, 4:15 PM EST - 8 months ago

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

Dec 19, 2024, 10:09 AM EST - 9 months ago

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SNPS

Dec 9, 2024, 7:30 AM EST - 10 months ago

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Nov 21, 2024, 7:30 AM EST - 10 months ago

IDEXX Announces CFO Transition

Nov 12, 2024, 9:00 AM EST - 11 months ago

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

Nov 10, 2024, 7:50 PM EST - 11 months ago

IDEXX Laboratories Q3: Weak End-Market Demand Continues

Oct 31, 2024, 1:59 PM EDT - 11 months ago

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 1:15 PM EDT - 11 months ago

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 12:55 PM EDT - 11 months ago

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

Oct 31, 2024, 8:01 AM EDT - 11 months ago

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

Oct 31, 2024, 6:30 AM EDT - 11 months ago

IDEXX Laboratories Announces Third Quarter Results

Sep 30, 2024, 2:00 PM EDT - 1 year ago

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

Aug 21, 2024, 4:15 PM EDT - 1 year ago

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 11, 2024, 11:36 PM EDT - 1 year ago

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Aug 6, 2024, 12:48 PM EDT - 1 year ago

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Aug 6, 2024, 12:46 PM EDT - 1 year ago

IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 3:20 AM EDT - 1 year ago

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

AAPL ABNB AMZN BAX CAT CSX DIS

highnihilism Sep. 16 at 4:46 PM

S&P 500 → $IDXX Idexx Laboratories $TKO Tko $CI Cigna $PNC PNC Financial $SO Southern

0 · Reply

highnihilism Sep. 16 at 3:43 PM

Nasdaq 100 → $KHC Kraft Heinz Company $IDXX Idexx Laboratories $TEAM Atlassian $BIIB Biogen $REGN Regeneron Pharmaceuticals

0 · Reply

SmartMoneyTradez Sep. 16 at 2:39 PM

$MDB $UTHR $IDXX 100 dollar gappers. Short candidates imo if the market unravels $SPY

0 · Reply

BillionerOfKing Sep. 16 at 2:10 PM

0 · Reply

MoneyGroupLLC Sep. 13 at 10:29 AM

Enter: $IDXX OCT 17 2025 $640 CALLS Buy in Price: $24.50 - $24.80 Take Profit: $27.28 Stop Bleeding: $21.82 ROI Potential: 10% Exit Within: 28 Minutes https://moneygroup.us/alerts

0 · Reply

ZacksResearch Sep. 12 at 2:16 PM

0 · Reply

ZacksResearch Sep. 12 at 1:07 PM

0 · Reply

NVDAMillionaire Sep. 9 at 11:06 AM

0 · Reply

StockAutoPro Sep. 8 at 12:54 AM

$IDXX: Buy target $640.99 Sell target $675.14 Positive trends in pet healthcare could boost shares in this veterinary diagnostic products manufacturer.

0 · Reply

StockAutoPro Sep. 7 at 5:04 PM

$IDXX: Buy target $640.99 Sell target $675.14 Strong earnings growth and robust pet adoption trends signal potential upside for this veterinary diagnostics stock.

0 · Reply

StockAutoPro Sep. 7 at 6:33 AM

$IDXX: Buy target $640.99 Sell target $675.14 Expect potential growth due to increasing demand for veterinary diagnostic products and services.

0 · Reply

Quantum_Capital_LLC Sep. 5 at 8:19 PM

$IDXX I got really lucky on this IDXX call option because IDXX was in a real slump at that time (Dec) and now it is 643.00, well beyond my initial 580 in 12-months prediction. Do your DD. Long term

0 · Reply

MyChicago Sep. 5 at 4:06 PM

$ZOMDF Looking at a possible bull flag here. We are trying to break through 0.08. up 91% this week. We are rolling again. Time to buy. $WOOF $IDXX $CHWY $ELAN

0 · Reply

MyChicago Sep. 4 at 6:23 PM

$ZOMDF up 33% yesterday, today Zomedica is up22%. $WOOF $CHWY $ELAN $IDXX . Zomedica is the baby, they are working hard across around the globe in expansion. New horizons are opening for Zomedica.

0 · Reply

Juan787 Sep. 3 at 10:08 PM

$ZOMDF $IDXX took so many years to be what it is today… not comparing just an example to what buddy below said.

0 · Reply

WallStreetBuyDip Sep. 1 at 12:59 PM

$HELE trading at $25 with volume 41% below average, while $IDXX priced at $647 with volume 54% below average. Both in the Pets sector, but IDXX showing significantly higher price and lower volume compared to HELE. Is the Pets sector seeing a slowdown in investor interest?

0 · Reply

ZacksResearch Aug. 27 at 12:46 PM

$IDXX: 33% gain in a year, but what’s fueling the rise? 🚀 📈 CAG Diagnostics' international recurring revenue up 11% organically in Q2 2025 🌐 Cloud-based solutions in high demand ✅ Zacks Rank #2 (Buy) with consistent earnings beats See why IDXX could keep climbing here 👉 https://www.zacks.com/stock/news/2743276/should-you-add-idexx-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2743276-body-9690&ADID=SYND_STOCKTWITS_TWEET_2_2743276_BODY_9690

0 · Reply

ZacksResearch Aug. 27 at 11:46 AM

$IDXX — buy signal or debt trap? 📈⚠️ The company’s strong CAG Diagnostics momentum and rising cloud software demand are fueling growth, but its debt levels remain a key concern. Full bull vs. bear case here 👉 https://www.zacks.com/stock/news/2743276/should-you-add-idexx-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2743276-teaser-9689&ADID=SYND_STOCKTWITS_TWEET_2_2743276_TEASER_9689

0 · Reply

TheUnseenHand Aug. 27 at 9:34 AM

$IDXX choppy movement, waiting for clearer direction.

0 · Reply

ZacksResearch Aug. 25 at 1:24 PM

$IDXX surges 56.2% YTD — Is it time to ride the wave? 🚀 Despite industry challenges, IDEXX continues to outperform with an 11% organic rise in international CAG diagnostics and double-digit growth in cloud-native PIMS platforms. The company also raised its 2025 financial outlook, expecting total revenue growth of 7.7-9.7% and EPS growth of 16-20% YoY. 📈 See what makes IDEXX a solid wealth creator now 👉 https://www.zacks.com/stock/news/2741980/idexx-gains-562-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741980-body-9259&ADID=SYND_STOCKTWITS_TWEET_2_2741980_BODY_9259

0 · Reply

ZacksResearch Aug. 25 at 12:24 PM

$IDXX up 56% in a year — but what’s fueling the surge? 📈 Strong diagnostics growth, cloud software momentum, and an upbeat 2025 outlook are powering the rally. Full breakdown of what’s driving IDXX higher 👉 https://www.zacks.com/stock/news/2741980/idexx-gains-562-in-a-year-whats-driving-the-rally?cid=sm-stocktwits-2-2741980-teaser-9258&ADID=SYND_STOCKTWITS_TWEET_2_2741980_TEASER_9258

0 · Reply

StockAutoPro Aug. 23 at 4:01 PM

$IDXX: Buy target $643.55 Sell target $677.83 Strong pet adoption trends could boost growth for a leading veterinary diagnostics company.

0 · Reply

Market Cap	51.29B
Revenue (ttm)	3.90B
Net Income (ttm)	887.87M
EPS (ttm)	N/A
PE Ratio	53.72
Forward PE	51.18
Profit Margin	22.78%
Debt to Equity Ratio	0.36

Volume	120,317
Avg Vol	576,246
Day's Range	N/A - N/A
Shares Out	80.01M
Stochastic %K	61%
Beta	1.56
Analysts	Strong Sell
Price Target	$722.60